Current clinical issues on mycoses in neutropenic patients

International Journal of Antimicrobial Agents

Volumn 6, Issue 3, 1996, Pages 135-140

  Meunier, Françoise ^a  

^a NONE   (Belgium)

Author keywords

Clinical issues; Mycoses; Neutropenia

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ASPERGILLUS; CANCER PATIENT; CANDIDA; CLINICAL RESEARCH; CONFERENCE PAPER; FUSARIUM; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TRICHOSPORON;

EID: 0030007860     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(95)00045-3     Document Type: Conference Paper

References (31)

1. Meunier F. (Guest Editor) Invasive fungal infections in cancer patients. Bailliére's Clinical Infectious Diseases 1995;2:1-209.
2. Bodey G, Bueltmann B, Duguid W et al. J. Fungal infections in cancer patients: an international autopsy survey. Eur J Microbiol Infect Dis 1992;11(suppl 2):99-109.
3. Walsh TJ, Pizzo PA. Nosocomial fungal infections. Annu Rev Microbiol 1988;42:517-547.
4. Pfaller MA. Epidemiological typing for mycoses. Clin Infect Dis 1992;14(Suppl 1):S4-S10.
5. Viscoli C, Girmenia C, Marinus A, Martino P, Meunier F and the Invasive Fungal Infection Group (IFIG) of the European Organization of Research and Treatment of Cancer (EORTC). A surveillance study of fungemia in cancer patients. Abstract 44, 7th European Congress of Clinical Microbiology and Infectious Diseases, 26-30 March 1995.
6. Cohen J, Denning DW, Viviani MA and EORTC Invasive Fungal Infections Cooperative Group. Epidemiology of invasive aspergillosis in European cancer centers. Eur J Clin Microbiol Infect Dis 1993;12:392-393.
7. De Bock R and EORTC Invasive Fungal Infections Cooperative Group. Epidemiology of invasive fungal infections in bone marrow transplantation. Bone Marrow Transplant 1994;14(Suppl 5):S1-S2.
8. Wade JC. Epidemiology of Candida infections. In: Bodey GP (eds) Candidiasis: Pathogenesis, Diagnosis and Treatment. Raven Press, New York, 1993, pp. 85-109.
9. Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein G, Tyras D. Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989;27:2426-2428.
10. Doebbeling B, Hollis R, Isenberg H, Wenzel R, Pfaller M. Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections. J Clin Microbiol 1991;29(6):1268-1270.
11. Sharp AM, Odds FC, Evans EGV. Candida strains from neonates in a special care baby unit. Arch Dis Child 1992;67:48-52.
12. Aisner J, Schimpff SC, Bennett JE et al. Aspergillus infection in cancer patients. Association with fire proofing material in a new hospital. JAMA 1976;235:411-412.
13. Weber DJ, Rutala WA. Epidemiology of hospital-acquired fungal infections. In: Holmberg K, Meyer R (eds) Diagnosis and Therapy of Systemic Fungal Infections. Raven Press, New York 1989, pp. 1-24.
14. De Bock R, Gyssens I, Peetermans M. Aspergillus in pepper. Lancet 1989;331-332.
15. Meunier-Carpentier F, Kiehn T, Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med 1981;1:363-370.
16. Merz WG, Karp JE, Schrom D, Saral R. Increased incidence of fungemia caused by Candida krusei. J Clin Microb 1986;24:581-584.
17. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992;14(suppl 1):S120-S125.
18. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;2:379-390.
19. Lecciones J, Lee J, Navarro E et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992;14:875-883.
20. McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: report of ten cases of fungemia including three cases of endophthalmitis. Clin Infect Dis 1992; 14:472-478.
21. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):S43-S53.
22. Rinaldi MG. Selected medically important fungi with common synonyms and other obsolete names. Clin Infect Dis 1993;16:610-611.
23. Aisner J, Schimpff S, Sutherland J, Young V, Wiernick P. Torulopsis glabrata infections in patients with cancer increasing incidence and relationship to colonization. Am J Med 1976;61:23-28.
24. Sanford GR, Merz WG, Wingard JR, Sarache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980;142:503-509.
25. Edwards JE. Invasive Candida infections. Evolution of a fungal pathogen. N Engl J Med 1991;324:1060-1062.
26. Meunier F. Management of candidemia. N Engl J Med 1994; 331:1371-1372.
27. Rex J, Bennett JE, Sugar AM et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1326-1330.
28. Sculier JP, Bron D, Coune A, Meunier F. Successful treatment with liposomal amphotericin B in two patients with persisting fungemia. Eur J Clin Microbiol Infect Dis 1989;8:903-907.
29. Anaissie FJ, White MH, Uzun O et al. Amphotericin B lipid complex vs amphotericin B for treatment of invasive candidiasis: a prospective randomized multicenter trial. Abstract LM21, 35th ICAAC, San Francisco, CA, 1995.
30. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990;12:1147-1201.
31. Bodey G, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Inf Dis 1993;17:705-707.